The American biotechnology company Moderna has stated that it plans to increase the production of COVID-19 vaccines to 3 billion doses in 2022.
/AP / Associated Press / East News /Eastern news
The company predicts it will ship between 800 million and 1 billion doses worldwide this year, but next year most countries will still need the first batch of vaccinations against COVID-19. Modern also wants to be prepared for the possibility that people will need a so-called booster dose of the vaccine, from the Associated Press.
The Moderna vaccine is approved for adults in the US, EU countries and many other countries. The company is soon expecting data from a U.S. study on a two-dose vaccine for children ages 12 to 17, and has begun testing the vaccine for younger children. Research is also being conducted on vaccines adapted to the mutant coronavirus variant.
Free program – settle PIT 2020